Your browser doesn't support javascript.
loading
Hypoxia promotes breast cancer cell invasion through HIF-1α-mediated up-regulation of the invadopodial actin bundling protein CSRP2.
Hoffmann, Céline; Mao, Xianqing; Brown-Clay, Joshua; Moreau, Flora; Al Absi, Antoun; Wurzer, Hannah; Sousa, Barbara; Schmitt, Fernando; Berchem, Guy; Janji, Bassam; Thomas, Clément.
Afiliação
  • Hoffmann C; Laboratory of Experimental Cancer Research, 84 Val Fleuri, L-1526, Luxembourg, Luxembourg.
  • Mao X; Laboratory of Experimental Cancer Research, 84 Val Fleuri, L-1526, Luxembourg, Luxembourg.
  • Brown-Clay J; Laboratory of Experimental Cancer Research, 84 Val Fleuri, L-1526, Luxembourg, Luxembourg.
  • Moreau F; Laboratory of Experimental Cancer Research, 84 Val Fleuri, L-1526, Luxembourg, Luxembourg.
  • Al Absi A; Laboratory of Experimental Cancer Research, 84 Val Fleuri, L-1526, Luxembourg, Luxembourg.
  • Wurzer H; Laboratory of Experimental Cancer Research, 84 Val Fleuri, L-1526, Luxembourg, Luxembourg.
  • Sousa B; Faculaty of Science, Technology and Communication, University of Luxembourg, 2 avenue de l'Université, L-4365, Esch-sur-Alzette, Luxembourg.
  • Schmitt F; IPATIMUP- Institute of Molecular Pathology and Immunology of the University of Porto, Medical Faculty of Porto University, Rua Julio Amaral de Carvalho 45, 4200-135, Porto, Portugal.
  • Berchem G; IPATIMUP- Institute of Molecular Pathology and Immunology of the University of Porto, Medical Faculty of Porto University, Rua Julio Amaral de Carvalho 45, 4200-135, Porto, Portugal.
  • Janji B; Laboratory of Experimental Cancer Research, 84 Val Fleuri, L-1526, Luxembourg, Luxembourg.
  • Thomas C; Laboratory of Experimental Cancer Research, 84 Val Fleuri, L-1526, Luxembourg, Luxembourg.
Sci Rep ; 8(1): 10191, 2018 07 05.
Article em En | MEDLINE | ID: mdl-29976963
Hypoxia is a common feature of solid tumours that promotes invasion and metastatic dissemination. Invadopodia are actin-rich membrane protrusions that direct extracellular matrix proteolysis and facilitate tumour cell invasion. Here, we show that CSRP2, an invadopodial actin bundling protein, is upregulated by hypoxia in various breast cancer cell lines, as well as in pre-clinical and clinical breast tumour specimens. We functionally characterized two hypoxia responsive elements within the proximal promoter of CSRP2 gene which are targeted by hypoxia-inducible factor-1 (HIF-1) and required for promoter transactivation in response to hypoxia. Remarkably, CSRP2 knockdown significantly inhibits hypoxia-stimulated invadopodium formation, ECM degradation and invasion in MDA-MB-231 cells, while CSRP2 forced expression was sufficient to enhance the invasive capacity of HIF-1α-depleted cells under hypoxia. In MCF-7 cells, CSRP2 upregulation was required for hypoxia-induced formation of invadopodium precursors that were unable to promote ECM degradation. Collectively, our data support that CSRP2 is a novel and direct cytoskeletal target of HIF-1 which facilitates hypoxia-induced breast cancer cell invasion by promoting invadopodia formation.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Proteínas Nucleares / Regulação Neoplásica da Expressão Gênica / Subunidade alfa do Fator 1 Induzível por Hipóxia / Matriz Extracelular / Proteínas com Domínio LIM / Proteínas Musculares Tipo de estudo: Prognostic_studies Limite: Adult / Aged / Animals / Female / Humans / Middle aged Idioma: En Revista: Sci Rep Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Luxemburgo

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Proteínas Nucleares / Regulação Neoplásica da Expressão Gênica / Subunidade alfa do Fator 1 Induzível por Hipóxia / Matriz Extracelular / Proteínas com Domínio LIM / Proteínas Musculares Tipo de estudo: Prognostic_studies Limite: Adult / Aged / Animals / Female / Humans / Middle aged Idioma: En Revista: Sci Rep Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Luxemburgo